Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Humana ( (HUM) ) has provided an update.
Between March 3, 2025, and March 31, 2025, Humana Inc.’s senior management will meet with investors and analysts to reaffirm their guidance for the fiscal year ending December 31, 2025. The company projects diluted earnings per common share of approximately $15.88 and adjusted earnings per common share of approximately $16.25. This reaffirmation aligns with previous guidance issued in February 2025 and highlights Humana’s use of Adjusted EPS as a tool for evaluating core business operations and decision-making. The announcement underscores Humana’s commitment to providing a comprehensive perspective on its financial performance, which could influence stakeholder confidence and market positioning.
More about Humana
Humana Inc. operates in the healthcare industry, primarily offering health insurance services. The company focuses on providing a range of health insurance products and services to individuals and groups, with a significant emphasis on Medicare plans.
YTD Price Performance: 7.03%
Average Trading Volume: 1,764,577
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: $32.62B
See more insights into HUM stock on TipRanks’ Stock Analysis page.